| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30.8M | — | +15.2% |
| Cost of Revenue | $7.5M | — | -4.3% |
| Gross Profit | $23.4M | — | +23.2% |
| R&D Expense | $9.4M | — | +25.2% |
| SG&A Expense | $12.2M | — | +8.3% |
| Operating Income | -$5.1M | — | +34.2% |
| Pre-tax Income | -$5.0M | — | +23.7% |
| Income Tax | $63K | — | +110.0% |
| Net Income | -$8.0M | — | +12.8% |
| EPS (Basic) | -$0.05 | — | +16.7% |
| EPS (Diluted) | -$0.05 | — | +16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $37.4M | -14.1% | -33.5% |
| Short-term Investments | $21.6M | -12.7% | -55.5% |
| Accounts Receivable | $17.9M | +103.5% | +67.2% |
| Current Assets | $93.1M | -4.9% | -33.5% |
| Total Assets | $161.3M | -5.2% | -14.3% |
| Current Liabilities | $51.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $7.4M | — | -63.9% |
| Investing Cash Flow | $2.9M | — | -10.6% |
| Financing Cash Flow | -$17.9M | — | -245.2% |
| -11.4% |
| Total Liabilities | $52.9M | +29.1% | -10.7% |
| Stockholders' Equity | -$55.9M | -83.5% | -231.1% |